SkinHealth Systems Inc.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $103.9M
- Price
- $0.6533
- % Change (Daily % change from the live per-ticker quote feed.)
- +3.19%
- Volume
- 388.2K
About
SkinHealth Systems Inc., a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions in the Americas, the Asia-Pacific, Europe, the Middle East, Africa, Canada, and Latin America. The company's flagship product is HydraFacial, which enhances the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. It also offers Syndeo devices, which are delivery systems that are designed to connect providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling and nanoneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive peptide solutions and take home sprays for treating scalp health. In addition, it operates the MyBeautyHealth mobile application for consumers to earn loyalty points and unlock savings, log skin concerns and receive personalized treatment plans, and find and connect with Hydrafacial providers, as well as offers boosters. The company was formerly known as The Beauty Health Company and changed its name to SkinHealth Systems Inc. in April 2026. The company was founded in 1997 and is headquartered in Long Beach, California.
Quick stats
Shares outstanding127.5M
Computed float34.2M
Float / shares26.8%
Key info
SectorHealthcare
IndustryMedical - Specialties
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001818093
AI Summary
AI-generated1/19
standardmixedearnings
SkinHealth Systems Reports Second Quarter 2026 Financial Results
SkinHealth Systems reported Q2 2026 revenue of $72.1 million, down 7.8% year-over-year, driven by a 19.5% decline in delivery system sales to 770 units.
Despite the top-line contraction, Adjusted EBITDA increased 22% to $17.0 million, exceeding guidance, as gross margin expanded 560 basis points to 68.4% and adjusted operating expenses decreased.
For the full fiscal year 2026, the company maintained guidance for net sales of $280 million to $290 million and Adjusted EBITDA of $39 million to $46 million, reflecting continued sales pressure alongside sustained cost discipline.
Red flags
- Revenue declined 7.8% YoY and delivery system sales dropped nearly 20%
- Risk factors cite 'minimum bid price deficiency and the proposed reverse stock split'
- Securities class action settlement proposed
- Convertible senior notes totaling $103.1 million current portion mature in October 2026